Close

Provectus Biopharma (PVCT), POETIC Enter Childhood Cancers Treatment Research Agreement

December 8, 2016 6:15 AM EST Send to a Friend
Provectus Biopharmaceuticals, Inc. (OTC: PVCT) and POETrIC, The Pediatric Oncology Experimental Therapeutics Investigators Consortium, a group of 10 top-tier academic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login